Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002)
Conditions:   Human Papilloma Virus;   Cervical Cancer;   Vulvar Cancer;   Vaginal Cancer;   Genital WartsInterventions:   Biological: Octavalent HPV with 15 mcg IMX / AAHS;   Biological: Octavalent HPV with 30 mcg IMX / AAHS;   Biological: Octavalent HPV with 60 mcg IMX / AAHS;   Biological: Octavalent HPV with 120 mcg IMX / AAHS;   Biological: Comparator: Quadrivalent HPV Vaccine (qHPV), (GARDASIL™)Sponsor:   Merck Sharp & Dohme Corp.Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2009 Category: Research Source Type: clinical trials

Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002)
Conditions:   Human Papilloma Virus;   Cervical Cancer;   Vulvar Cancer;   Vaginal Cancer;   Genital WartsInterventions:   Biological: Octavalent HPV with 15 mcg IMX / AAHS;   Biological: Octavalent HPV with 30 mcg IMX / AAHS;   Biological: Octavalent HPV with 60 mcg IMX / AAHS;   Biological: Octavalent HPV with 120 mcg IMX / AAHS;   Biological: Comparator: Quadrivalent HPV Vaccine (qHPV), (GARDASIL™)Sponsor:   Merck Sharp & Dohme Corp.Completed - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2009 Category: Research Source Type: clinical trials

Pelvic Exenteration for Gynecologic Malignancy
Conditions:   Cervical Cancer;   Endometrial Cancer;   Vaginal Cancer;   Vulvar Cancer;   Gynecologic CancerIntervention:   Behavioral: QuestionnairesSponsor:   M.D. Anderson Cancer CenterRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2008 Category: Research Source Type: clinical trials

Pelvic Exenteration for Gynecologic Malignancy
Conditions:   Cervical Cancer;   Endometrial Cancer;   Vaginal Cancer;   Vulvar Cancer;   Gynecologic CancerIntervention:   Behavioral: QuestionnairesSponsor:   M.D. Anderson Cancer CenterRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2008 Category: Research Source Type: clinical trials

Pelvic Exenteration for Gynecologic Malignancy
Conditions:   Cervical Cancer;   Endometrial Cancer;   Vaginal Cancer;   Vulvar Cancer;   Gynecologic CancerIntervention:   Behavioral: QuestionnairesSponsor:   M.D. Anderson Cancer CenterRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2008 Category: Research Source Type: clinical trials